Answers are grounded in this paper and cite their sources.
Narrative review highlights molecular mechanisms driving CD8+ T-cell immunity against HIV-1, suggesting critical pathways for rational vaccine design.
PURPOSE OF REVIEW: This review aims to deepen our appreciation of the intricate interactions underpinning CD8+ T-cell-mediated immunity to HIV-1, from the whole-cell level to the structure and function of signalling molecules driving diverse transcriptional programmes and differentiation states. RECENT FINDINGS: Unravelling the signals that trigger T-cell activation, elucidating the dynamic architecture of the immunological synapse, and comprehensive, high-resolution tissue cell atlases are transforming our understanding of T-cell biology during viral infections. SUMMARY: This review links multiple processes that together generate T-cell immunity with possible implications for vaccine development. It begins by examining the role of T-cell-mediated responses in protection against HIV-1 and the importance of targeting vulnerable epitopes on HIV-1 proteins to suppress viral replication. It then zooms in on the initiation of T-cell activation, differentiation, and effector functions, mediated by the formation of the immunological synapse, co-stimulatory signalling, and cytokine networks, which drive coordinated actions of multiple transcription factors and chromatin remodelling. It emphasizes the importance of T-cell diversity, the continuum of cellular differentiation states, tissue localization, and memory formation in shaping effective antiviral immunity.
No takes yet. Share an insight, caveat, or question.
Tomáš Hanke (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: